Cite

    Takeuchi, T. et al. (2018). Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual‐dose proton pump inhibitor: Acotiamide plus usual‐dose proton pump inhibitor versus double‐dose proton pump inhibitor. Journal of gastroenterology and hepatology. 33 (3), pp. 623-630. [Online].